CLINICAL_TRIALS
trial_result
· 2011-02-21
Clinical Trial Update: Efficacy of SLITone in House Dust Mite Allergic Patients [Phase 2, Phase 3]
Summary
Phase 2/3 trial updates show efficacy results for SLITone in house dust mite–related allergic rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-02-21